Pharma industry steps up API investments to cut import dependence, move up value chain
The man behind Lord’s Mark: Dr. Sachidanand Upadhyay features in TIME Magazine for the third consecutive year- Aayush Wellness reports 10.6% rise in first-half income
- Govt plans instant ban on manufacturing of drugs failing key quality tests
- FeaturedUTI Large Cap Direct-G2.255.410.0210.02
- -3.560.564.2717.23
- -3.720.334.1217.20
- Biocon CEO forecasts H2 results to outperform H1; company posts 52% fall in Q2 net profit; revenue up 2%
- Inside Park Hospitals' regional playbook: Why North India depth matters more than national reach
- Wockhardt seeks 14-year data shield for India-made drugs
- HRV Pharma buys Germany's Phatebo
- NPPA updates list of reduced MRP of 1,085 anti-cancer drugs
- Alkem Laboratories appoints Amrut Naik as CEO
- High Court restrains NPPA from action against AstraZeneca
- Wockhardt expands novel antibiotic Miqnaf's access; Q2 revenue rises 24%
- Experts say health technology, preventive healthcare at inflection point, India ready to leverage
- India’s medicine sales grow in double digits for four straight quarters, led by chronic care drugs
- India's first public sector proton beam therapy unit to come up in Assam; state signs MoU with Belgian firm
Top Mutual Funds
3 M(%)
6 M(%)
1 YR(%)
3 YRS(%)
MORE NEWS
Biotech
FSSAI pulls up Dr Reddy's, Nestle Health Science over Celevida claims- Lord’s Mark strengthens UK and UK allied market strategy with regulatory backing for IVD portfolio.
- NDude Labs invests in nutraceutical ingredients firm Nutriventia
- MSD inaugurates 2.5 lakh sq ft tech centre in Hyderabad
- Govt eases loan licence requirement for 'outsourced' sterilisation of medical gear
Healthcare
'Liquid biopsy can ease financial burden for cancer patients': Scientists on how a $1,000 test could save $10,000 in treatment costs- Pharma industry steps up API investments to cut import dependence, move up value chain
- Arunoday Singh-headed O-Health secures strategic funding
- The man behind Lord’s Mark: Dr. Sachidanand Upadhyay features in TIME Magazine for the third consecutive year
- Aayush Wellness reports 10.6% rise in first-half income
Pharmaceuticals
More than family business: Drugmakers make costly, long-term strategic shifts as next generation steps into bigger roles- Cancer drug prices to fall by up to 96% from November 9; consumers set to save Rs 3,502 crore annually
- Bayer signs MoU with Karnataka government for ₹200 crore manufactuing facility near Bengaluru
- FDA flags persistent data-integrity lapses, insanitary conditions at Indian drug facilities
- Dr Reddy's Laboratories receives ANVISA approval for generic semaglutide injection in Brazil